Results 151 to 159 of about 5,421 (159)

Sulbactam/Durlobactam

Clinical Therapeutics
openaire   +2 more sources

Beyond resistance: assessing sulbactam-durlobactam’s role in today’s clinical landscape

Expert Review of Anti-infective Therapy
openaire   +2 more sources

Comparative in vitro activity of sulbactam with avibactam or durlobactam against carbapenem-resistant Acinetobacter baumannii

JAC-Antimicrobial Resistance
Yohei Doi, Ryan Shields, Marissa P Griffith   +2 more
exaly  

Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii

Future Microbiology
Navaneeth Narayanan, John O'Donnell, John Mills   +2 more
exaly  

Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK)

Antimicrobial Agents and Chemotherapy
Samir Moussa, Alita Miller, Sarah McLeod   +2 more
exaly  

Genomic characterization of Carbapenem-Resistant Acinetobacter baumannii clinical strains resistant to Sulbactam/Durlobactam from Italy

European Journal of Clinical Microbiology & Infectious Diseases
Luca, Caiazzo, Gabriele, Bianco, Matteo, Boattini, Cristina, Costa, Paolo, Gaibani   +4 more
openaire   +2 more sources

In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex

Diagnostic Microbiology and Infectious Disease
Patricia Bradford, Nicole Carter, Alita Miller   +2 more
exaly  

A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp.

Antimicrobial Agents and Chemotherapy
Carlo Tascini, Abi Manesh, Robert Bonomo   +2 more
exaly  

Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

Annals of Pharmacotherapy
Pramodini Kale-Pradhan, Andrew Matlob
exaly